ODANACATIB TREATMENT OF POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY: 3-YEAR CONTINUED THERAPY AND RESOLUTION OF EFFECT

被引：0
|
作者：
Rizzoli, R. [1 ]
Eisman, J. A. [2 ]
Bone, H. [3 ]
Hosking, D. [4 ]
McClung, M. [5 ]
Reid, I. [6 ]
Resch, H. [7 ]
Verbruggen, N. [8 ]
Santora, A. [9 ]
Hustad, C. [9 ]
Lombardi, A. [9 ]
机构：
[1] Univ Hosp Cantonal, Geneva, Switzerland
[2] St Vincents Hosp, Garvan Inst Med Res, Sydney, NSW 2010, Australia
[3] Michigan Bone & Mineral Ctr, Detroit, MI USA
[4] City Hosp Nottingham, Nottingham, England
[5] Oregon Osteoporosis Ctr, Portland, OR USA
[6] Univ Auckland, Auckland 1, New Zealand
[7] St Vincents Hosp, Vienna, Austria
[8] Merck Res Labs, Brussels, Belgium
[9] Merck Res Labs, Rahway, NJ USA
来源：
OSTEOPOROSIS INTERNATIONAL | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：27 / 27
页数：1
相关论文
共 50 条
  • [21] Romosozumab in postmenopausal women with low bone mineral density
    Tornero Marin, C.
    REVISTA CLINICA ESPANOLA, 2014, 214 (06): : 345 - 345
  • [22] Romosozumab in postmenopausal women with low bone mineral density
    Schurman, Leon
    ACTUALIZACIONES EN OSTEOLOGIA, 2014, 10 (02) : 206 - 208
  • [23] Effect of two year treatment with hormone replacement therapy (HRT) on bone mineral density (BMD) in postmenopausal women with SLE.
    Sanchez-Guerrero, FJ
    Gonzelez-Perez, M
    Jasqui, S
    Uribe-Lima, A
    Garcia-Moreno, C
    Lara-Reyes, P
    Durand-Carbajal, M
    Jimenez-Santata, ML
    Correa-Rotter, R
    Cravioto, MC
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S290 - S290
  • [24] FOUR-YEAR RESULTS OF A PHASE 2 STUDY OF THE CATESPIN K INHIBITOR ODANACATIB IN POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY: EFFECTS ON BONE TURNOVER MARKERS
    Papapoulos, Socrates
    Rodriguez Portales, Jose
    Petrovic, Romana
    Rosenberg, Elizabeth
    DaSilva, Carolyn
    Santora, Arthur
    Lombardi, Antonio
    Binkley, Neil
    Bone, Henry
    Eisman, John
    Hosking, David
    Langdahl, Bente
    McClung, Michael
    Reid, Ian
    Resch, Heinrich
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 113 - 114
  • [25] Does continued alendronate therapy improve bone mineral density and reduce fracture risk in postmenopausal women?
    Kraenzlin, Marius E.
    Meier, Christian
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (10): : 686 - 687
  • [26] Does continued alendronate therapy improve bone mineral density and reduce fracture risk in postmenopausal women?
    Marius E Kraenzlin
    Christian Meier
    Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 : 686 - 687
  • [27] Effect of Teprenone (GGA) with Etidronate(EHDP) on lumbar bone mineral density in postmenopausal women with low bone mineral density
    Shintani, M
    Beppu, K
    Hara, Y
    BONE, 2003, 32 (05) : S209 - S209
  • [28] Effect of exercise on bone mineral density in postmenopausal women
    Ross, MD
    Denegar, CR
    STRENGTH AND CONDITIONING JOURNAL, 2001, 23 (04) : 30 - 35
  • [29] Odanacatib, a Cathepsin-K Inhibitor for Osteoporosis: A Two-Year Study in Postmenopausal Women With Low Bone Density
    Bone, Henry G.
    McClung, Michael R.
    Roux, Christian
    Recker, Robert R.
    Eisman, John A.
    Verbruggen, Nadia
    Hustad, Carolyn M.
    DaSilva, Carolyn
    Santora, Arthur C.
    Ince, B. Avery
    JOURNAL OF BONE AND MINERAL RESEARCH, 2010, 25 (05) : 937 - 947
  • [30] The Effect of Acupuncture on Bone Mineral Density in Postmenopausal Women
    欧阳钢
    王玲玲
    王东岩
    卓铁军
    申志祥
    周永生
    Journal of Traditional Chinese Medicine, 2002, (01) : 9 - 11
12345